Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain - PubMed (original) (raw)
Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain
R R Mattingly et al. Mol Cell Biol. 1994 Dec.
Abstract
Expression of certain subtypes of human muscarinic receptors in NIH 3T3 cells provides an agonist-dependent model of cellular transformation by formation of foci in response to carbachol. Although focus formation correlates with the ability of the muscarinic receptors to activate phospholipase C, the actual mitogenic signal transduction pathway is unknown. Through cotransfection experiments and measurement of the activation state of native and epitope-tagged Ras proteins, the contributions of Ras and Ras GTPase-activating protein (Ras-GAP) to muscarinic receptor-dependent transformation were defined. Transforming muscarinic receptors were able to activate Ras, and such activation was required for transformation because focus formation was inhibited by coexpression of either Ras with a dominant-negative mutation or constructs of Ras-GAP that include the catalytic domain. Coexpression of the N-terminal region of GAP or of its isolated SH3 (Src homology 3) domain, but not its SH2 domain, was also sufficient to suppress muscarinic receptor-dependent focus formation. Point mutations at conserved residues in the Ras-GAP SH3 domain reversed its action, leading to an increase in carbachol-dependent transformation. The inhibitory effect of expression of the Ras-GAP SH3 domain occurs proximal to Ras activation and is selective for the mitogenic pathway activated by carbachol, as cellular transformation by either v-Ras or trkA/nerve growth factor is unaffected.
Similar articles
- The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.
Xu N, McCormick F, Gutkind JS. Xu N, et al. Oncogene. 1994 Feb;9(2):597-601. Oncogene. 1994. PMID: 8290270 - Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.
Huang DC, Marshall CJ, Hancock JF. Huang DC, et al. Mol Cell Biol. 1993 Apr;13(4):2420-31. doi: 10.1128/mcb.13.4.2420-2431.1993. Mol Cell Biol. 1993. PMID: 8455619 Free PMC article. - Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels.
Yatani A, Quilliam LA, Brown AM, Bokoch GM. Yatani A, et al. J Biol Chem. 1991 Nov 25;266(33):22222-6. J Biol Chem. 1991. PMID: 1939245 - Ras regulatory interactions: novel targets for anti-cancer intervention?
Prendergast GC, Gibbs JB. Prendergast GC, et al. Bioessays. 1994 Mar;16(3):187-91. doi: 10.1002/bies.950160309. Bioessays. 1994. PMID: 8166672 Review. - Pumping the brakes on RAS - negative regulators and death effectors of RAS.
Harrell Stewart DR, Clark GJ. Harrell Stewart DR, et al. J Cell Sci. 2020 Feb 10;133(3):jcs238865. doi: 10.1242/jcs.238865. J Cell Sci. 2020. PMID: 32041893 Free PMC article. Review.
Cited by
- A nuclear export signal is essential for the cytosolic localization of the Ran binding protein, RanBP1.
Richards SA, Lounsbury KM, Carey KL, Macara IG. Richards SA, et al. J Cell Biol. 1996 Sep;134(5):1157-68. doi: 10.1083/jcb.134.5.1157. J Cell Biol. 1996. PMID: 8794858 Free PMC article. - The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.
Chang HY, Chang HM, Wu TJ, Chaing CY, Tzai TS, Cheng HL, Raghavaraju G, Chow NH, Liu HS. Chang HY, et al. J Biomed Sci. 2017 Aug 26;24(1):61. doi: 10.1186/s12929-017-0360-x. J Biomed Sci. 2017. PMID: 28841878 Free PMC article. - Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.
Hu KQ, Settleman J. Hu KQ, et al. EMBO J. 1997 Feb 3;16(3):473-83. doi: 10.1093/emboj/16.3.473. EMBO J. 1997. PMID: 9034330 Free PMC article. - Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.
Aiyar SE, Sun JL, Blair AL, Moskaluk CA, Lu YZ, Ye QN, Yamaguchi Y, Mukherjee A, Ren DM, Handa H, Li R. Aiyar SE, et al. Genes Dev. 2004 Sep 1;18(17):2134-46. doi: 10.1101/gad.1214104. Genes Dev. 2004. PMID: 15342491 Free PMC article. - High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis.
Beqaj S, Jakkaraju S, Mattingly RR, Pan D, Schuger L. Beqaj S, et al. J Cell Biol. 2002 Mar 4;156(5):893-903. doi: 10.1083/jcb.200107049. Epub 2002 Mar 4. J Cell Biol. 2002. PMID: 11877460 Free PMC article.
References
- Cell. 1992 Aug 7;70(3):431-42 - PubMed
- Science. 1992 Dec 4;258(5088):1665-8 - PubMed
- Nature. 1993 May 27;363(6427):309-10 - PubMed
- Science. 1987 Jul 31;237(4814):527-32 - PubMed
- Mol Cell Biol. 1991 May;11(5):2812-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous